Alterity director reports ATHE share and option stakes
ALTERITY THERAPEUTICS LTD director Lawrence Bernard Gozlan has filed an initial Form 3 showing his indirect holdings in the company.
Rhea-AI Filing Summary
ALTERITY THERAPEUTICS LTD director Lawrence Bernard Gozlan has filed an initial Form 3 showing his indirect holdings in the company. The filing reports 4,545,455 ordinary shares held indirectly through Montoya Pty Ltd <Buttercup A/C>.
He also indirectly holds listed options over 1,515,152 ordinary shares with a conversion price of $0.028 per share, expiring on 26 February 2027, and unlisted options over 50,000,000 ordinary shares with a conversion price of $0.010 per share, expiring on 30 December 2027. The Form 3 records these positions as existing holdings rather than new market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Gozlan Lawrence Bernard
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Listed option exp 26 Feb 2027 | -- | -- | -- |
| holding | Unlisted option exp 30 Dec 2027 | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
Holdings After Transaction:
Listed option exp 26 Feb 2027 — 1,515,152 contracts (Indirect, Montoya Pty Ltd <Buttercup A/C>);
Unlisted option exp 30 Dec 2027 — 50,000,000 contracts (Indirect, Montoya Pty Ltd <Buttercup A/C>);
Ordinary shares — 4,545,455 shares (Indirect, Montoya Pty Ltd <Buttercup A/C>)
Key Figures
Indirect ordinary shares: 4,545,455 shares
Listed options underlying: 1,515,152 shares
Listed option exercise price: $0.028 per share
+2 more
5 metrics
Indirect ordinary shares
4,545,455 shares
Indirect holdings via Montoya Pty Ltd <Buttercup A/C>
Listed options underlying
1,515,152 shares
Options expiring 26 Feb 2027, exercise price $0.028
Listed option exercise price
$0.028 per share
Conversion or exercise price for listed options
Unlisted options underlying
50,000,000 shares
Options expiring 30 Dec 2027, exercise price $0.010
Unlisted option exercise price
$0.010 per share
Conversion or exercise price for unlisted options
Key Terms
Form 3, listed option, unlisted option, indirect ownership, +1 more
5 terms
Form 3 regulatory
"The Form 3 records these positions as existing holdings rather than new market purchases or sales."
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
listed option financial
"He also indirectly holds listed options over 1,515,152 ordinary shares with a conversion price of $0.028 per share."
unlisted option financial
"and unlisted options over 50,000,000 ordinary shares with a conversion price of $0.010 per share."
indirect ownership financial
"The filing reports 4,545,455 ordinary shares held indirectly through Montoya Pty Ltd <Buttercup A/C>."
exercise price financial
"with a conversion price of $0.028 per share, expiring on 26 February 2027"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the ATHE Form 3 filed by Lawrence Bernard Gozlan show?
The Form 3 shows initial beneficial ownership for director Lawrence Bernard Gozlan in Alterity Therapeutics. It lists his indirect holdings of ordinary shares and options through Montoya Pty Ltd <Buttercup A/C>, without reporting any new market purchases or sales.
What listed options are reported for Gozlan in the ATHE Form 3?
The Form 3 lists listed options expiring 26 February 2027 over 1,515,152 underlying ordinary shares, with a conversion or exercise price of $0.028 per share. These options are held indirectly via Montoya Pty Ltd <Buttercup A/C>.
What unlisted options does Gozlan have in Alterity Therapeutics (ATHE)?
Gozlan indirectly holds unlisted options expiring 30 December 2027 over 50,000,000 underlying ordinary shares of Alterity Therapeutics. The Form 3 states a conversion or exercise price of $0.010 per share for these options, held through Montoya Pty Ltd <Buttercup A/C>.
Does the ATHE Form 3 indicate any insider buying or selling by Gozlan?
The Form 3 records holdings only and shows unknown transaction codes, with no buy or sell counts. It functions as an initial statement of beneficial ownership, not as a disclosure of recent market purchases or sales of ATHE securities.
AI-generated analysis. How Rhea-AI works. Not financial advice.
